Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Recombinant Proteins Market Set To Climb From $2.89 Billion In 2026 To $4.84 Billion By 2030
The size of the recombinant proteins market has seen rapid expansion recently. Its projected growth trajectory shows an increase from $2.55 billion in 2025 to $2.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. Factors contributing to its historical growth include the expanding development of biologics-based drugs, the growing incidence of autoimmune and chronic diseases, the proliferation of protein-based diagnostics, the broader application of recombinant insulin, and improvements in expression system efficiency.
The recombinant proteins market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $4.84 billion in 2030, achieving a compound annual growth rate (CAGR) of 13.7%. This expansion during the forecast period is fueled by the increasing embrace of next-generation biologics, rising investments directed towards biomanufacturing facilities, the growing need for personalized therapeutics, the broadening scope of biosimilar development, and the increased utilization of recombinant proteins in research. Prominent trends expected in the forecast period involve a boost in the production of therapeutic antibodies, an escalating demand for recombinant enzymes, the wider adoption of protein engineering techniques, an increase in biologics manufacturing capacity, and a heightened focus on high-purity protein expression.
Get A Free Sample Report With In-Depth Market Insights:
Recombinant Proteins Market Growth Drivers: What’s Behind The Acceleration?
The increasing focus on personalized medicine is anticipated to drive the expansion of the recombinant protein market in the future. Personalized medicine defines a healthcare strategy where treatments and therapies are customized to a patient’s specific characteristics, genetic makeup, and requirements, aiming for more precise and impactful health results. The rise of personalized medicine is due to innovations in genomic technologies and data analytics, which facilitate the creation of customized treatments aligned with unique genetic profiles. Recombinant proteins facilitate personalized medicine by supporting the creation of bespoke therapies designed to target an individual’s distinct genetic and molecular blueprint, thereby enhancing treatment efficacy and mitigating adverse effects. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, marking a substantial increase from the 6 approved in 2022. Consequently, the heightened attention on personalized medicine is fueling the growth of the recombinant protein market moving forward.
Recombinant Proteins Market Breakdown By Product Type And Application
The recombinant proteins market covered in this report is segmented –
1) By Product: Antibodies, Cytokines, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies
2) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factors (TNFs)
3) By Virus Antigens: Viral Capsid Proteins, Envelope Proteins
4) By Enzymes: Restriction Enzymes, Polymerases, Ligases
5) By Recombinant Regulatory Proteins: Transcription Factors, Receptors
6) By Hormones: Insulin, Growth Hormones
7) By Other Products: Fusion Proteins, Peptide Therapeutics
Recombinant Proteins Market Trends: What’s Defining The Industry’s Next Phase?
Leading firms within the recombinant protein market are forming alliances to enhance their competitive position. Such collaborations frequently stimulate innovation through the integration of varied organizational expertise. As an illustration, in October 2023, ARTES Biotechnology GmbH, a biotechnology firm based in Germany, entered into a collaboration with Basic Pharma, a pharmaceutical company located in the Netherlands. This joint effort includes a strategic partnership and a co-marketing agreement, with objectives centered on the development and production of non-GMP recombinant proteins, emphasizing the creation of an optimized supply chain to accelerate the introduction of novel pharmaceutical products to the market.
Recombinant Proteins Market Leading Companies And Competitive Benchmarking
Major companies operating in the recombinant proteins market are Abcam plc, Abnova Corporation, Bio-Rad Laboratories Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Eli Lilly and Company
View The Full Recombinant Proteins Market Report:
Recombinant Proteins Market Top Region By Revenue And Market Share
North America was the largest region in the recombinant protein market in 2025. The regions covered in the recombinant proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
